Publication | Closed Access
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
1.1K
Citations
24
References
2015
Year
Surgical OncologyHepatologyMedicineSurgeryLiver CancerCancer TreatmentOncologyRadiation OncologyAdjuvant SorafenibHepatocellular CarcinomaPhase 3
| Year | Citations | |
|---|---|---|
Page 1
Page 1